The U.S. Congressional Budget Office (CBO) estimates that eliminating the limit on rebates that drug manufacturers pay to Medicaid, now capped at 100 percent of a drug’s average manufacturer price (AMP), “would reduce direct spending in Medicaid by $15.9 billion
…
Two U.S. Senate committees have scheduled hearings next week on President Biden’s nomination of California Attorney General Xavier Becerra to be the next U.S. Health and Human Services (HHS) Secretary. In December, Becerra helped spearhead a bipartisan letter of
…
Several news organizations report that the Biden administration will nominate former federal executive and legislative branch health policy official Chiquita Brooks-LaSure to serve as Administrator of the Center for Medicare & Medicaid Services (CMS). The White House had not announced
…Generic liquid drug manufacturer Pharmaceutical Associates, Inc. (PAI), has notified 340B covered entities on the U.S. Health Resources and Services Administration (HRSA) website about 340B overcharges and potential credit/rebill repayments regarding all of its products covering the first through third
…The U.S. Health Resources and Services Administration (HRSA) is “ramping up” its work with the Biden administration “and bringing forth the key issues and concerns of” the 340B program, Rear Adm. Krista Pedley, the program’s director, said today in a
…
Drug manufacturer AstraZeneca on Friday asked the federal district judge in Delaware handling its 340B contract pharmacy lawsuit against the federal government either to issue a preliminary injunction in its favor or expedite court proceedings “to prevent imminent irreparable harm”
…
The U.S. House Energy and Commerce Committee on Friday passed pandemic-relief legislation with language that could cause pharmaceutical manufacturers to owe states Medicaid drug rebates worth more than a drug’s average manufacturer price (AMP). It could also result in additional
…
A Pulitzer Prize-winning journalism website that fact-checks politicians’ claims has waded into the controversy over whether President Biden raised insulin prices by freezing a 340B-related Trump administration regulation.
On Feb. 11, the Poynter Institute’s PolitiFact site rated U.S. Senate
…
A federal district judge in Oakland, Calif., on Tuesday expressed doubt that she had jurisdiction to require the U.S. Health and Human Services Department (HHS) to make drug manufacturers repay 340B hospitals for drug discounts that the companies have declined
…The U.S. House Energy and Commerce Committee is scheduled to mark up COVID-19 relief legislation today with language that could cause pharmaceutical manufacturers to owe states Medicaid drug rebates worth more than a drug’s average manufacturer price (AMP).
The language
…
×
*Sign up for news summaries and alerts from 340B Report